Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
drugs
100%
nanoparticles
84%
drug delivery
39%
cancer
37%
polymers
35%
inflammation
31%
in vitro
28%
antibiotics
25%
isoniazid
25%
surfaces
23%
toxicity
23%
glycolic acid
22%
evaluation
19%
dendrimers
18%
prednisolone
18%
curcumin
18%
cataracts
18%
delivery
18%
therapy
18%
indium hydrides
18%
stability
17%
surgery
15%
comparative evaluations
15%
reviews
14%
synthesis
13%
hyaluronic acid
13%
mycobacterium tuberculosis
13%
in vivo
12%
administration
12%
folic acid
12%
oxadiazoles
12%
implants
12%
strains
12%
applications
12%
receptors
11%
uptake
11%
patients
10%
eyes
10%
carriers
10%
design
10%
ph value
9%
tumors
9%
molecules
9%
encapsulation
9%
tuberculosis
8%
assessments
8%
attenuation
8%
interactions
8%
brain
8%
lungs
8%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
79%
Malignant Neoplasm
27%
Isoniazid
25%
Polyglactin
23%
Paclitaxel
21%
Rifampicin
20%
Cytotoxicity
19%
Dendrimer
18%
Prednisolone
18%
Curcumin
18%
Diseases
18%
Drug Delivery System
14%
Mycobacterium Tuberculosis
13%
Bioavailability
12%
Folic Acid
12%
Cataract
12%
Nanomedicine
12%
Oxadiazole Derivative
12%
Biomaterial
12%
Anticarcinogen
10%
Drug Resistance
10%
Poly(amidoamine)
10%
Neoplasm
9%
Nervous System Inflammation
8%
Nanomaterial
8%
Inflammation
8%
Hyperbarism
8%
Breast Cancer
8%
Drug Release
8%
Drug Formulation
7%
Disease
7%
Hydrazone Derivative
7%
Anti-Inflammatory Drug
7%
Fluocinolone Acetonide
7%
Hyaluronic Acid
7%
High Performance Liquid Chromatography
6%
Antiinfective Agent
6%
Scanning Electron Microscopy
6%
Chlamydiasis
6%
Nanocomposite
6%
Antimycobacterial Agent
6%
Therapeutic Window
6%
Bioassay
6%
Epidermal Growth Factor Receptor
6%
Functional Groups
6%
Methylprednisolone
6%
Isoniazid Derivative
6%
Pneumonia
6%
Targeted Drug Delivery
6%
Implant
6%